Yayın: Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study
| dc.contributor.author | Gülbaş, Zafer | |
| dc.contributor.author | Myriam Labopin | |
| dc.contributor.author | Emanuele Angelucci | |
| dc.contributor.author | Fabio Ciceri | |
| dc.contributor.author | José L. Díez‐Martín | |
| dc.contributor.author | Benedetto Bruno | |
| dc.contributor.author | Simona Sica | |
| dc.contributor.author | Yener Koç | |
| dc.contributor.author | Zafer Gülbaş | |
| dc.contributor.author | Christoph Schmid | |
| dc.contributor.author | Didier Blaise | |
| dc.contributor.author | Angelo Michele Carella | |
| dc.contributor.author | Giuseppe Visani | |
| dc.contributor.author | Bipin N. Savani | |
| dc.contributor.author | Arnon Nagler | |
| dc.contributor.author | Mohamad Mohty | |
| dc.contributor.orcid | 0000-0003-2371-3655 | |
| dc.contributor.orcid | 0000-0003-4514-4748 | |
| dc.contributor.orcid | 0000-0002-6512-6080 | |
| dc.contributor.orcid | 0000-0003-0873-0123 | |
| dc.contributor.orcid | 0000-0003-1869-0129 | |
| dc.contributor.orcid | 0000-0002-7299-6770 | |
| dc.contributor.orcid | 0000-0003-2426-3465 | |
| dc.contributor.orcid | 0000-0002-3919-9649 | |
| dc.contributor.orcid | 0000-0002-4709-0627 | |
| dc.contributor.orcid | 0000-0001-7070-487X | |
| dc.contributor.orcid | 0000-0002-5684-9447 | |
| dc.contributor.orcid | 0000-0002-4967-4204 | |
| dc.contributor.orcid | 0000-0002-3304-9965 | |
| dc.contributor.orcid | 0000-0002-0763-1265 | |
| dc.date.accessioned | 2025-11-13T23:05:01Z | |
| dc.date.issued | 2019-11-13 | |
| dc.identifier.doi | https://doi.org/10.1182/blood-2019-122279 | |
| dc.identifier.endpage | 4584 | |
| dc.identifier.issn | 0006-4971 | |
| dc.identifier.issue | Supplement_1 | |
| dc.identifier.openalex | W4205311416 | |
| dc.identifier.startpage | 4584 | |
| dc.identifier.uri | https://hdl.handle.net/11421/16277 | |
| dc.identifier.uri | https://doi.org/10.1182/blood-2019-122279 | |
| dc.identifier.volume | 134 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Blood | |
| dc.rights | restrictedAccess | |
| dc.subject | Medicine | |
| dc.subject | Total body irradiation | |
| dc.subject | Busulfan | |
| dc.subject | Fludarabine | |
| dc.subject | Internal medicine | |
| dc.subject | Cyclophosphamide | |
| dc.subject | ThioTEPA | |
| dc.subject | Transplantation | |
| dc.subject | Regimen | |
| dc.subject | Leukemia | |
| dc.subject | Surgery | |
| dc.subject | Chemotherapy | |
| dc.subject | Oncology | |
| dc.subject | Hematopoietic stem cell transplantation | |
| dc.subject | Cumulative incidence | |
| dc.subject | Cohort | |
| dc.subject | Gastroenterology | |
| dc.subject.sdg | 1 | |
| dc.title | Outcomes of Total Body Irradiation- Versus Chemotherapy-Based Myeloablative Conditioning Regimen in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide for Acute Myelogenous Leukemia: ALWP of the EBMT Study | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5058571002 |
